Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4368_Библиотеки_им_академика_М_И_Перельмана
.pdf
Nasopharyngectomy
https://t.me/med1917
enhancement (FICE) and autofluorescence imaging.34
These technologies have been developed to improve
mucosal visualization and to enhance or complement
traditional white light endoscopy. Narrow-band
imaging using a blue light filter highlights superficial
mucosal vasculature. The blue filter corresponds to
the peak absorption spectrum of hemoglobin and
further enhances visualization of mucosal vasculature.
Therefore, narrow-band imaging is a useful tool to
detect the neoangiogenesis of early malignant mucosal
35,36
lesions.
NPCs demonstrate an irregular engorged
vascular pattern, a microvascular proliferative pattern,
absence of surface patterns, and/or a “‘reverse’ haphazard
follicular pattern” with a dark brown center and pale
periphery.
37,38
Narrow-band imaging has a reported
sensitivity of 78 to 93.9%, specificity of 95.5%, positive
predictive value of 97%, and negative predictive value of
70 to 98.1%.
34,37,39
Chemoendoscopy uses a filter to restrict
incident wavelengths to correspond to the absorption
peaks of hemoglobin (415–540 nm) which improves the
contrast between the vasculature and mucosa.
34
FICE or
i-scan applies an image processing algorithm to white
light images based on spectral emission methods and has
a high sensitivity and specicificity.
34
Autofluorescence
endoscopy sequentially radiates both excitation light
(370–470 nm) and green light (540–560 nm) which
excites endogenous fluorophores (e.g., collagen).
Dysplasia or early invasive malignancies are displayed
as magenta on a pseudocolor image.
34
Autofluorescence
34
has a reported accuracy for distinguishing between
hyperplastic colonic polyps and adenomas of up to 88.4%;
however, it has been shown to have a high false-positive
rate of up to 81%.
34
Finally, confocal laser endomicroscopy
uses laser light focused through a pinhole to improve
image resolution to a subcellular level and has a sensitivity
and specificity that ranges between 76 and 97% and 72
and 99%, respectively.
Surgery does offer comparable or better local control
rates than re-irradiation
treatment modality for radioresistant tumors.
34
4,11,12,14,40–42
and is the primary
2,18,19
Endoscopic surgery results in less severe complications,
less intraoperative blood loss, shorter operating times,
and a shorter length of stay when compared with open
surgery.
re-irradiation,
43
Surgery also results in less morbidity than
11,14,15
which often produces significant
complications and sequelae such as neck fibrosis,
deafness, trismus, cranial neuropathies, endocrine
dysfunction, and temporal lobe necrosis.
44
However,
surgery is limited to a select group of patients. Patients
who present with significant involvement of the ICA
or extension into the cavernous sinus or spine are not
surgical candidates, as surgery will cause significant
morbidity and will not alter the outcome.
26.6 Contraindications to
Surgery and Complications
We have described an endoscopic endonasal approach to
nasopharyngeal tumors; however, open and combined
approaches are also viable options, depending on the
tumor type, location, and extent. Castelnuovo et al
have developed a grading system of surgical resection
according to the extent of the disease (Table 26.1).45
Endonasal approaches have the advantage of utilizing
the preexistent sinonasal air spaces and provide
magnified access to the central skull base without the
need for external incisions, translocation/disruption of
the maxillofacial skeleton, and excessive dissection as
part of the approach. Endoscopic nasopharyngectomy
can achieve negative margins in up to 97% of
appropriately selected patients.
are extremely selected, as endoscopic approaches are
limited by their relationship to critical neurovascular
structures such as the ICA and optic nerves. A pure
endoscopic approach is limited/contraindicated
for tumors surrounding the parapharyngeal ICA or
extending posterior to the parapharyngeal or petrous
ICA. Some authors have suggested that there be a
distance of at least 1 cm between the tumor and the
ICA for it to be considered endoscopically resectable.
Other authors have suggested only rT1, rT2, and select
rT3 tumors with limited skull base, brain, or dural
involvement are amenable to endoscopic resection.
However, Al-Sheibani et al
demonstrated that endoscopic approaches can be used
for T3 and T4 tumors adjacent to but not involving
the ICA. Therefore, there are no absolute guidelines
regarding the approach chosen.
Extensive dural involvement is also a relative
contraindication to an endonasal approach. Certain
key features on MRI have been shown to be highly
predictive of dural invasion. These features include
pial enhancement, loss of the hypointense zone,
discontinuous dural enhancement, focal dural nodules,
and more than 2 to 5 mm of dural thickening.
approaches range in their exposure and morbidity
but can be divided in two main categories according
to their direction of approach, lateral and anterior.
Lateral approaches include the pre- and postauricular
approaches, usually involving orbitozygomatic
2,46
However, patients
2
and Castelnuovo et al17
48–50
Open
47
43
Table 26.1 Classifi cation of surgical resection by extent of disease
NER subtype Surgical resection
1 Posterior septectomy, resection of posterosuperior nasopharyngeal wall to, but not including, the bone fl oor of
2 Resection includes fl oor and anterior wall of sphenoid sinus
3 Resection includes lateral wall of nasopharynx and car tilaginous eustachian tube
Abbreviation: NER, nasopharyngeal endoscopic resection.
Source: Castelnuovo et al.
the sphenoid sinus superiorly and pharyngobasilar/prevertebral fascia posteriorly. Ventral clivus is drilled down.
Cartilaginous eustachian tube is preserved
45
275

Nasopharyngectomy
https://t.me/med1917
osteotomies and a subtemporal craniectomy. In addition,
the postauricular approach involves a transtemporal
corridor. Anterior approaches include the midfacial
degloving Le Forte I osteotomy, the facial translocation
or maxillary swing approach, and the transcervicalmandibulotomy-palatal approach. However, a large
open approach does not equate a corresponding
increase of exposure in the nasopharynx, as they often
provide limited access. Morbidity associated with open
approaches occurs in up to 54% of patients and includes
velopharyngeal incompetence, palatal dysfunction, and
trismus.
the development of transoral robotic-assisted surgery.
11,12
Future directions for nasopharyngeal surgery include
51–53
Robotic surgery does not require transection of the palate
to access the nasopharynx; however, this technique is still
limited by the lack of devices that allow the resection of
bone and adequate suction.
26.7 Conclusion
An endoscopic endonasal approach to nasopharyngeal
tumors offers excellent access and visualization to this
difficult region. An EEA also provides the ability to
adequately control critical neurovascular structures,
appropriate oncologic resection with negative margins,
the ability to reconstruct with nearby pedicled
vascularized tissue, no external scars, and maximal
preservation of function. In select patients and with
an experienced team with specialized equipment, this
approach offers comparable, if not superior, outcomes to
traditional open approaches.
References
1. Brown JJ, Fee WE. Surgical resection of the nasopharynx. Oper
Tech Otolaryngol 2010;21(1):26–34
2. Al-Sheibani S, Zanation AM, Carrau RL, et al. Endoscopic endonasal transpterygoid nasopharyngectomy. Laryngoscope
2011;121(10):2081–2089
3. Lin J-C, Jan J-S, Hsu C-Y, Liang W-M, Jiang R-S, Wang W-Y. Phase III
study of concurrent chemoradiotherapy versus radiotherapy alone
for advanced nasopharyngeal carcinoma: positive effect on overall
and progression-free survival. J Clin Oncol 2003;21(4):631–637
4. Yu KH, Leung SF, Tung SY, et al; Hong Kong Nasopharyngeal
Carcinoma Study Group. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the
Hong Kong Nasopharyngeal Carcinoma Study Group. Head Neck
2005;27(5):397–405
5. Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and
regional control. Int J Radiat Oncol Biol Phys 1997;37(5):985–996
6. Sutton JB, Green JP, Meyer JL, Louie D, Heltzel M, Karp AH. Nasopharyngeal carcinoma. A study examining Asian patients treated
in the United States. Am J Clin Oncol 1995;18(4):337–342
7. Chan JY, Wei WI. Critical appraisal of maxillary swing approach for nasopharyngeal carcinoma. Expert Opin Ther Targets
2012;16(Suppl 1):S111–S117
8. Lee AWM, Law SCK, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 19761985: survival after local recurrence. Int J Radiat Oncol Biol Phys
1993;26(5):773–782
9. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma—treatment techniques and results. Int J Radiat Oncol Biol Phys
1987;13(7):953–956
10. Chua DT, Sham JS, Kwong DL, Wei WI, Au GK, Choy D. Locally recurrent nasopharyngeal carcinoma: treatment results for patients
with computed tomography assessment. Int J Radiat Oncol Biol
Phys 1998;41(2):379–386
11. King WW, Ku PK, Mok CO, Teo PM. Nasopharyngectomy in the
treatment of recurrent nasopharyngeal carcinoma: a twelve-year
experience. Head Neck 2000;22(3):215–222
12. Fee WE Jr, Moir MS, Choi EC, Goffinet D. Nasopharyngectomy for
recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch
Otolaryngol Head Neck Surg 2002;128(3):280–284
13. Fee WE Jr, Roberson JB Jr, Goffinet DR. Long-term survival after surgical resection for recurrent nasopharyngeal cancer
after radiotherapy failure. Arch Otolaryngol Head Neck Surg
1991;117(11):1233–1236
14. Hsu MM, Hong RL, Ting LL, Ko JY, Sheen TS, Lou PJ. Factors affecting the overall survival after salvage surgery in patients
with recurrent nasopharyngeal carcinoma at the primary site:
experience with 60 cases. Arch Otolaryngol Head Neck Surg
2001;127(7):798–802
15. Suárez C, Rodrigo JP, Rinaldo A, Langendijk JA, Shaha AR, Ferlito A.
Current treatment options for recurrent nasopharyngeal cancer.
Eur Arch Otorhinolaryngol 2010;267(12):1811–1824
16. Wu SX, Chua DT, Deng ML, et al. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and
recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys
2007;69(3):761–769
17. Castelnuovo P, Nicolai P, Turri-Zanoni M, et al. Endoscopic endonasal nasopharyngectomy in selected cancers. Otolaryngol Head
Neck Surg 2013;149(3):424–430
18. Chen AM, Bucci MK, Quivey JM, Garcia J, Eisele DW, Fu KK.
Long-term outcome of patients treated by radiation therapy
alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys
2006;66(4):1044–1050
19. Chen AM, Granchi PJ, Garcia J, Bucci MK, Fu KK, Eisele DW. Local-regional recurrence after surgery without postoperative irradiation
for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 2007;67(4):982–987
20. Chan JY, Chow VL, Mok VW, Ho AC, Wei WI. Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG
PET-CT scan in recurrent nasopharyngeal carcinoma. Head Neck
2012;34(4):541–545
21. Chan JYW, Wong STS. The role of plasma Epstein-Barr virus DNA
in the management of recurrent nasopharyngeal carcinoma.
Laryngoscope 2014;124(1):126–130
22. Vlantis AC, Tsang RK, Yu BK, et al. Nasopharyngectomy and surgical margin status: a survival analysis. Arch Otolaryngol Head Neck
Surg 2007;133(12):1296–1301
23. Hao SP, Tsang NM, Chang KP, Hsu YS, Chen CK, Fang KH. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a
review of 53 patients and prognostic factors. Acta Otolaryngol
2008;128(4):473–481
24. To EW, Lai EC, Cheng JH, Pang PC, Williams MD, Teo PM. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a
review of 31 patients and prognostic factors. Laryngoscope
2002;112(10):1877–1882
25. Hadad G, Bassagasteguy L, Carrau RL, et al. A novel reconstructive technique after endoscopic expanded endonasal approaches:
vascular pedicle nasoseptal flap. Laryngoscope 2006;116(10):
1882–1886
26. Fortes FSG, Carrau RL, Snyderman CH, et al. Transpterygoid
transposition of a temporoparietal fascia flap: a new method for
skull base reconstruction after endoscopic expanded endonasal
approaches. Laryngoscope 2007;117(6):970–976
27. Kasemsiri P, Carrau RL, Otto BA, et al. Reconstruction of the pedicled nasoseptal flap donor site with a contralateral reverse rotation flap: technical modifications and outcomes. Laryngoscope
2013;123(11):2601–2604
28. Lee HY, Kim HU, Kim SS, et al. Surgical anatomy of the sphenopalatine artery in lateral nasal wall. Laryngoscope 2002;112(10):
1813–1818
29. Becker AM, Hwang PH. Endoscopic endonasal anatomy of the
nasopharynx in a cadaver model. Int Forum Allergy Rhinol
2013;3(4):319–324
30. Caicedo-Granados E, Carrau R, Snyderman CH, et al. Reverse
rotation flap for reconstruction of donor site after vascular
pedicled nasoseptal flap in skull base surgery. Laryngoscope
2010;120(8):1550–1552
31. Yen RF, Hung RL, Pan MH, et al. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance
imaging. Cancer 2003;98(2):283–287
32. Chan AT, Ma BB, Lo YM, et al. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent
cisplatin in patients with locoregionally advanced nasopharyngeal
carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA. J Clin Oncol 2004;22(15):3053–3060
33. Chen L, Cui TT, Wang G, Li LY, Shi WY, Ni XX. Intra-nasal scanning
of tumors in nasal cavity and paranasal sinus with endoscopic ultrasonography [Chinese]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke
Za Zhi 2007;42(1):23–26
276

Nasopharyngectomy
https://t.me/med1917
34. Subramanian V, Ragunath K. Advanced endoscopic imaging: a review of commercially available technologies. Clin Gastroenterol
Hepatol 2014;12(3):368–76.e1
35. Piazza C, Dessouky O, Peretti G, Cocco D, De Benedetto L, Nicolai P.
Narrow-band imaging: a new tool for evaluation of head and neck
squamous cell carcinomas. Review of the literature. Acta Otorhinolaryngol Ital 2008;28(2):49–54
36. Lin YC, Wang WH. Narrow-band imaging for detecting early recurrent nasopharyngeal carcinoma. Head Neck 2011;33(4):591–594
37. Ho CY, Lee YL, Chu PY. Use of narrow band imaging in evaluation of possible nasopharyngeal carcinoma. Am J Rhinol Allergy
2011;25(2):107–111
38. Thong JF, Loke D, Karumathil Sivasankarannair R, Mok P. Use of
narrow-band imaging in detection of nasopharyngeal carcinoma. J
Laryngol Otol 2013;127(2):163–169
39. Wen YH, Zhu XL, Lei WB, Zeng YH, Sun YQ, Wen WP. Narrow-band
imaging: a novel screening tool for early nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2012;138(2):183–188
40. Chen C, Fee W, Chen J, et al. Salvage treatment for locally recurrent nasopharyngeal carcinoma (NPC). Am J Clin Oncol
2014;37(4):327–331
41. Kasemsiri P, Prevedello DM, Ditzel L, et al. Surgical treatment of
nasopharyngeal malignancies: role of endoscopic endonasal approaches. J Nasopharyngeal Carcinoma 2014;1(14):e14
42. Hsu NI, Shen PH, Chao SS, Ong YK, Li CS. En bloc resection concept
for endoscopic endonasal nasopharyngectomy: surgical anatomy
and outcome. Chin Med J (Engl) 2014;127(16):2934–2939
43. Ong YK, Solares CA, Lee S, Snyderman CH, Fernandez-Miranda J,
Gardner PA. Endoscopic nasopharyngectomy and its role in managing locally recurrent nasopharyngeal carcinoma. Otolaryngol
Clin North Am 2011;44(5):1141–1154
44. Leung TW, Tung SY, Sze WK, et al. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol
Phys 2000;48(5):1331–1338
45. Castelnuovo P, Dallan I, Bignami M, et al. Nasopharyngeal endoscopic resection in the management of selected malignancies: tenyear experience. Rhinology 2010;48(1):84–89
46. Ho AS, Kaplan MJ, Fee WE Jr, Yao M, Sunwoo JB, Hwang PH.
Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Int Forum Allergy Rhinol
2012;2(2):166–173
47. Chen MY, Wen WP, Guo X, et al. Endoscopic nasopharyngectomy
for locally recurrent nasopharyngeal carcinoma. Laryngoscope
2009;119(3):516–522
48. Eisen MD, Yousem DM, Montone KT, et al. Use of preoperative MR
to predict dural, perineural, and venous sinus invasion of skull
base tumors. AJNR Am J Neuroradiol 1996;17(10):1937–1945
49. McIntyre JB, Perez C, Penta M, Tong L, Truelson J, Batra PS. Patterns
of dural involvement in sinonasal tumors: prospective correlation
of magnetic resonance imaging and histopathologic findings. Int
Forum Allergy Rhinol 2012;2(4):336–341
50. Ahmadi J, Hinton DR, Segall HD, Couldwell WT. Surgical implications of magnetic resonance-enhanced dura. Neurosurgery
1994;35(3):370–377, discussion 377
51. Ozer E, Waltonen J. Transoral robotic nasopharyngectomy:
a novel approach for nasopharyngeal lesions. Laryngoscope
2008;118(9):1613–1616
52. Wei WI, Ho WK. Transoral robotic resection of recurrent nasopharyngeal carcinoma. Laryngoscope 2010;120(10):2011–2014
53. Tsang RKY, Ho WK, Wei WI, Chan JY. Transoral robotic assisted
nasopharyngectomy via a lateral palatal flap approach. Laryngoscope 2013;123(9):2180–2183
277

https://t.me/med1917

V
Section 7
https://t.me/med1917
Combined Endoscopic–
27 Transbasal/Subfrontal-
Transcribriform Approach
to Anterior Skull Base 281
Transcranial Approaches
28 Retrosigmoid–Transclival
Approach 293
29 Far Lateral-Craniovertebral
Approach 303
30 Anterior Transpetrosal
Approach versus EEA
Transclival Approach 315
II

https://t.me/med1917

Chapter 27
https://t.me/med1917
27.1 Indications 282
Transbasal/ Subfrontal-
Transcribriform
Approach to Anterior
Skull Base
27.2 Surgical Steps 282
27.3 Case Example 290
27.4 Complications 291
27.5 Instruments Required 291
27.6 Tips and Tricks 291

Transbasal/Subfrontal-Transcribriform Approach to Anterior Skull Base
https://t.me/med1917
27 Transbasal/Subfrontal-Transcribriform Approach
to Anterior Skull Base
Iacopo Dallan, Mario Turri-Zanoni, Stefano Sellari-Franceschini
Introduction
Although there is terrific advancement of endonasal endoscopic procedures, there are still lesions/conditions
of the anterior cranial base that require a combined
approach. This kind of approach is mainly indicated
in case of sinonasal tumors needing a dural resection
extending over the orbital roof or with an extensive brain
involvement. Thanks to the combined transcranial/transnasal approach and the aid of straight and angled endoscope, this kind of procedure offers a multiperspective
visualization of the spaces allowing a more precise dissection and a sound reconstruction.
27.1 Indications
The endoscopic transnasal approach is generally combined to the transbasal (frontal)/subfrontal approach for
addressing different pathologies involving the anterior
cranial fossa, not amenable for an exclusive endonasal
approach.
such an approach are as follows:
• Extensive malignant tumors of the anterior skull base,
• Benign tumors of the sinonasal compartment with
• Inflammatory diseases affecting the frontoethmoid-
• Posttraumatic or spontaneous cerebrospinal fluid (CSF)
1
The diseases that can be treated by means of
representing the principal indication for the combined
cranio-endoscopic approach. Small- to intermediate
-sized sinonasal cancers can be approached through
an exclusive endoscopic transnasal transcribriform–
transethmoidal approach.2 However, in cases of extensive
anterior skull base involvement with massive infiltration
of the dura over the orbital roof or brain parenchyma infiltration, detected both in the preoperative or intraoperative settings, the pure endoscopic transnasal approach
should be combined with a transcranial frontal/subfrontal approach to obtain a radical resection.
massive frontal sinus involvement or intracranial extension over the orbital roof (e.g., inverted papilloma).
al compartments with osteitis and/or osteomyelitis.
In these cases, the diseased bone has to be removed
through an extended approach to control the infection
and limit the progression of the bony erosion.
leaks of the anterior skull base placed in difficult-toaccess areas or with an extensive fragmentation of the
anterior cranial fossa. In these cases, the exclusive endonasal approach may be difficult and ineffective.
1,3
27.2 Surgical Steps
The endonasal transcribriform–transethmoidal and the
subfrontal/transbasal approaches can be combined and
performed simultaneously by two different surgical teams
(neurosurgeons and otorhinolaryngologists), working together through the two corridors (multiportal combined
transnasal and transcranial endoscopic-assisted surgery).
The transcranial approach improves the control of the
supraorbital region and allows a better manipulation of
critical structures of anterior cranial base. The transnasal
technique allows more precise dissection of the sphenoethmoidal complex with a better management of the sinonasal region.
the endonasal view is especially useful for completing the
skull base reconstruction. Indeed, the endoscope makes
it possible to verify the watertight closure and to apply
eventually fascia in an overlay fashion, for buttressing the
anterior skull base reconstruction. The main surgical steps
comprised in such an approach are summarized below.
3
Moreover, at the end of the procedure,
27.2.1 Subtotal Septectomy
Removal of the posterior two-thirds of the nasal septum
is performed to gain better exposure of the surgical field
and to optimize the endonasal maneuverability of the
dedicated instruments, using the two-nostril four-hand
technique. The posterior septum is disarticulated from
the rostrum of the sphenoid bone, which is then removed
to create a bilateral opening in the sphenoid sinus that
represents the posteroinferior margin of the dissection.
The septal branches of sphenopalatine arteries are isolated and coagulated to reduce bleeding and improve visibility (Fig. 27.1).
27.2.2 Identifi cation of the First
Olfactory Fiber
The first olfactory fiber is identified in the olfactory region by means of a careful subperiosteal dissection. This
is done to define the starting point of the anterior cranial
fossa from an endoscopic endonasal perspective; this step
is very useful to perform safely a frontal sinusotomy according to Draf type III. It should be noted that the frontal
sinusotomy can be performed also with a lateral to medial
direction (this could be advisable in case of difficulties in
identifying the first olfactory fiber). This step, absolutely
mandatory in exclusively transnasal procedures, could be
unnecessary when the frontal sinuses are approached with
an additional transcranial opening (Fig. 27.2).
27.2.3 Frontal Sinusotomy
(Draf Type III Procedure)
The frontal sinusotomy (see Chapter 4 for detailed description) represents the anterosuperior margin of the dissection, allowing a precise control of the lesion to be treated
and its relationship with the anterior cranial fossa. The Draf
III median drainage consists in the removal of the frontal
sinus floor bilaterally together with the intersinus septum.
And as said, the Draf type III procedure can be performed
using a medial to lateral or a lateral to medial technique.
As mentioned before, endonasal frontal sinusotomy can
be unnecessary given the superior—transcranial—control
of the frontal sinuses (Fig. 27.3).
282

Transbasal/Subfrontal-Transcribriform Approach to Anterior Skull Base
https://t.me/med1917
MT
NS
IT
IT
a
Fig. 27.1 (a) The posterior portion of the nasal septum is removed. (b) Endonasal view of the two ethmoidal complexes after
removing the nasal septum. IT, inferior turbinate; MT, middle turbinate; NS, nasal septum; NSup, upper portion of the nasal septum.
b
NSup
MT
FS
OG
MT
Fig. 27.2 Endoscopic endonasal view of the olfactory region
(left side). The fi rst olfactory fi ber is indicated by the black
arrow. MT, middle turbinate; OG, olfactory groove.
27.2.4 Centripetal Resection of
Ethmoidal Box
Once the posteroinferior and anterosuperior margins
of the resection are exposed, a subperiosteal dissection
of the naso-ethmoidal complexes is performed to delineate the lateral borders of the area to be removed.
The lamina papyracea should be included in the dissection when the lesion to treat frankly involved it.
When required by the extension of disease, endoscopic
NSup
OM
Fig. 27.3 Endoscopic endonasal view of the frontal
sinusotomy according to Draf type III procedure. Once the Draf
type III procedure is performed, the “T shape” of the anatomic
structures (upper portion of the nasal septum and lateral
lamella of the cribriform plates bilaterally) is well evident. FS,
frontal sinus; NSup, upper portion of the nasal septum; OM,
olfactory mucosa.
medial maxillectomy can be performed, to achieve
good control of the whole maxillary sinus. This surgical phase has to be associated with nasolacrimal duct
exposure and resection, just below the lacrimal sac. In
very selected cases, the periorbita and extraconal fat
can be removed, if a very limited involvement of these
structures is present (Fig. 27.4).
4
283

Transbasal/Subfrontal-Transcribriform Approach to Anterior Skull Base
https://t.me/med1917
27.2.5 Completion of Centripetal
Resection
Superiorly, the dissection is completed, usually with
an anteroposterior direction, by resecting the olfactory mucosa and the basal lamella of the ethmoidal
turbinates, to resect the ethmoidal complexes in a centripetal way. Obviously when doing this step, all the
olfactory fibers are cut. The naso-ethmoidal complexes
are isolated and pushed toward the central part of the
ASB
MT
MT
nasal fossa (centripetal technique) to extract them
through the nasal vestibule or through the oral cavity
(Fig. 27.5).
27.2.6 Anterior Cranial Fossa
Exposure
The ethmoidal roof should be completely exposed with
removal of bony partitions by using a drill with a diamond burr. During this step, the anterior and posterior
OG OG
MTMT
4
IT
a
Fig. 27.4 (a) The ethmoidal dissection is shown on the right side. (b) Once the subperiosteal dissection is performed bilaterally, the
ethmoidal complexes of both sides remain attached only at the level of the anterior skull base. ASB, anterior skull base; IT, inferior
turbinate; MT, middle turbinate; OG, olfactory groove.
FS
NSup
AEA
b
CP
*
*
*
FE
*
a
Fig. 27.5 (a) The ethmoidal boxes are completely resected from the cribriform plates, exposing the anterior skull base. In this way,
the anterior and posterior ethmoidal arteries are visible, usually running in bony canals. (b) Once the anterior skull base is denuded
from the frontal sinus back to the sphenoid sinus, the olfactory fi bers appear evident. AEA, anterior ethmoidal artery; CP, cribriform
plate; FE, fovea ethmoidalis; FS, frontal sinus; NSup, upper portion of the nasal septum; black arrow indicates the posterior ethmoidal
artery; black asterisks point out the olfactory fi bers.
b
284
Соседние файлы в папке Библиотека им академика М.И. Перельмана
